DeepScribe
by DeepScribe, Inc.
DeepScribe is an ambient clinical documentation platform that records clinician-patient conversations and uses AI to draft medical notes. It integrates with electronic health record workflows and is designed for healthcare organizations.
Why Abandoned
DeepScribe’s official website remains live and continues to present its ambient clinical documentation platform, while 2025 company announcements describe active product development and commercial partnerships.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 96%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
DeepScribe founded
Matthew Ko and Akilesh Bapu founded DeepScribe in San Francisco to develop AI-assisted clinical documentation technology.
$30 million Series A announced
DeepScribe announced a $30 million Series A led by Index Ventures, with participation from The House Fund, Bee Partners, Stage 2 Capital and 1984 Ventures.
AWS healthcare collaboration announced
DeepScribe announced a strategic collaboration with Amazon Web Services focused on scaling its ambient clinical intelligence platform for healthcare organizations.
$30 million Series B announced
DeepScribe announced a $30 million Series B led by AVP, with participation from Index Ventures, Crosslink Capital and Slow Ventures.
DeepScribe and Flatiron Health partner
DeepScribe and Flatiron Health announced a partnership to bring ambient documentation capabilities into oncology workflows.
🔄 Alternatives to DeepScribe
Fireflies.ai
🟢ActiveAI notetaker that automatically records, transcribes, and analyzes voice conversations.
Otter.ai
🟢ActiveAI meeting assistant that records, transcribes, and summarizes meetings in real-time.
Tactiq
🟢ActiveTactiq is an AI meeting assistant and browser extension that transcribes Google Meet, Zoom, and Microsoft Teams calls. It can generate summaries, action items, follow-up text, and answers based on meeting transcripts.
Zoom AI Companion
🟢ActiveZoom AI Companion is a generative AI assistant built into Zoom Workplace. It can summarize meetings, identify action items, help draft chat and email messages, and answer questions using permitted workplace context.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is DeepScribe AI used for?
DeepScribe is used for ambient clinical documentation. It captures clinician-patient conversations and generates draft medical notes for review, editing and entry into electronic health record workflows.
Is DeepScribe still active?
Yes. DeepScribe appears active: its website continues to market the platform, and the company announced funding, product development and healthcare partnerships during 2025.
Does DeepScribe integrate with electronic health record systems?
DeepScribe says its platform supports EHR-integrated workflows. Exact compatibility and implementation details depend on the healthcare organization and should be confirmed with the company.
Who founded DeepScribe?
DeepScribe was founded by Matthew Ko and Akilesh Bapu in 2017.
How much funding has DeepScribe raised?
DeepScribe publicly announced a $30 million Series A in 2022 and a $30 million Series B in 2025. This record does not state a lifetime total because earlier financing amounts vary across secondary databases.